Invivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results and Business Highlights
August 03 2023 - 4:01PM
Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical
company on a mission to protect the vulnerable from serious viral
infectious diseases, today announced that it will host a conference
call on Thursday, August 10, 2023, at 4:30 p.m. ET to discuss its
financial results for the quarter ended June 30, 2023, and recent
business highlights.
Listeners can register for the webcast via this link. Analysts
wishing to participate in the question and answer session should
use this link. A replay of the webcast will be available in the
investor section of the company’s website approximately two hours
after the end of the call. Those who plan on participating are
advised to join 15 minutes prior to the start time.
About InvivydInvivyd, Inc. (Nasdaq: IVVD) is a
biopharmaceutical company on a mission to rapidly and perpetually
deliver antibody-based therapies that protect vulnerable people
from the devastating consequences of circulating viral threats,
beginning with SARS-CoV-2. Invivyd’s technology works at the
intersection of evolutionary virology, predictive modeling, and
antibody engineering, and is designed to identify high-quality,
long-lasting antibodies with the potential to resist viral escape.
The company is generating a robust pipeline of product candidates
which could be used in prevention or treatment of serious viral
diseases, starting with COVID-19 and expanding into influenza and
other high-need indications. Visit https://invivyd.com/ to learn
more.
Media Contact:Kate Burdick, Evoke
Canale860-462-1569kate.burdick@evokegroup.com
Investor Contact:Chris Brinzey, ICR
Westwicke339-970-2843chris.brinzey@westwicke.com
Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From Apr 2024 to May 2024
Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From May 2023 to May 2024